Leucoaraiosis and silent subcortical infarcts

Revue Neurologique

Volumn 164, Issue 10, 2008, Pages 801-804

  Norrving, B ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anticoagulants; Blood pressure; Leucoaraiosis; Silent brain infarcts; Stroke; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; WARFARIN; ANTITHROMBOCYTIC AGENT;

ANTICOAGULANT THERAPY; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN REGION; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; FIBRINOLYTIC THERAPY; HIGH RISK POPULATION; HUMAN; LEUKOARAIOSIS; LONG TERM CARE; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIOPERATIVE PERIOD; PROGNOSIS; RECURRENCE RISK; REVIEW; RISK BENEFIT ANALYSIS; SILENT SUBCORTICAL INFARCT; STROKE; SURGICAL RISK; SYMPTOMATOLOGY; TRANSIENT ISCHEMIC ATTACK; AGED; ALZHEIMER DISEASE; NEUROSURGERY; PATHOLOGY; RISK FACTOR; VASCULAR AMYLOIDOSIS;

AGED; ALZHEIMER DISEASE; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL INFARCTION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; NEUROSURGICAL PROCEDURES; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RISK FACTORS; STROKE;

EID: 58149154211     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2008.07.009     Document Type: Review

References (11)

1. Ay H., Arsava M., Rosand J., Furie K.L., Singhal A.B., Schaefer P.W., et al. Severity of leucoaraiosis and susceptibility to infarct growth in acute stroke. Stroke 39 (2008) 1409-1413
2. Corea F., Henon H., Pasquier F., and Leys D. Silent infarcts in stroke patients: patient characteristics and effects on 2-year outcome. J Neurol 248 (2001) 271-278
3. Dufouil C., Chalmers J., Coskun O., Besancon V., Bousser M.G., et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke. The PROGRESS (Perindopril protection against recurrent stroke study) Magnetic resonance imaging substudy. Circulation 112 (2005) 1644-1650
4. Fu J.H., Lu C.Z., Hong Z., Dong Q., Luo Y., and Wong K.S. Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke. J Neurol Neurosurg Psychiatry 76 (2005) 793-796
5. Hasegawa Y., Yamaguchi T., Omae T., Woodward M., Chalmers J, and PROGRESS CT Substudy Investigators. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarcts: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan. Hypertens Res 27 (2004) 147-156
6. Jörgensen H.S., Nakayama H., Raaschou H.O., and Olsen T.S. Silent infarction in acute stroke patients. Prevalence, risk factors, and clinical significance: the Copenhagen Stroke Study. Stroke 25 (1994) 97-104
7. Jörgensen H.S., Nakayama H., Raaschou H.O., and Olsen T.S. Leucoaraiosis in stroke patients. The Copenhagen Stroke Study. Stroke 36 (1995) 588-592
8. Neumann-Haefelin T., Hoelig S., Berkfeld J., Fiehler J., Gass A., Humpich M., et al. Leucoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 37 (2006) 2463-2466
9. Palumbo V, Boulanger JM, Inzitari D, Buchan AM, on behalf of the CASES Investigators. Leucoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007;68:1020-4.
10. Streifler J.Y., Eliaziw M., Benavente O.R., Alamowitch S., Fox A.J., et al. Prognostic importance of leucoaraiosis in patients with symptomatic internal carotid artery stenosis. Stroke 33 (2002) 1651-1655
11. Wiszniewska M., Devuyst G., Bogousslavsky J., Ghika J., and van Melle G. What is the significance of leucoaraiosis in patients with acute ischemic stroke?. Arch Neurol 57 (2000) 967-973